secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2024-01-05T23:59:59+00:00
Accession:  0000947871-24-000009
Event type: leadership
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVS names Tom Cowhey CFO, Mike Pykosz President of Health Care Delivery; reaffirms FY2023 and FY2024 guidance
--------------------------------------------------------------------------------

- Thomas F. Cowhey appointed EVP and CFO effective Jan 5, 2024; receives $1M base salary, target cash incentive 150%, and $5.5M equity award.
- Shawn Guertin steps down as CFO and President of Health Services due to family health reasons; will leave CVS on May 31, 2024.
- Mike Pykosz appointed President of Health Care Delivery; he was CEO of Oak Street Health and interim lead since Oct 13, 2023.
- Reaffirms 2023 GAAP EPS guidance $6.37-$6.61, Adjusted EPS $8.50-$8.70 (expects upper half); 2024 guidance at least $7.26 GAAP, $8.50 Adjusted.
- Expects Medicare Advantage membership growth of at least 800k in 2024; enrollment exceeded expectations during annual enrollment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000094787124000009/0000947871-24-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000094787124000009/ss2874786_8k.htm
  HTML page:      https://secwatch.observer/filing/0000947871-24-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer